Indian pharma industry estimated to grow 9 to 11 percent in FY22: ICRA Medical Dialogues Bureau5 Jan 2022 9:15 AM IST"Revenue growth for ICRA sample set is estimated at 9 to 11 per cent in FY2022 and in FY2023, supported by gradual recovery post the impact of COVID,"...
Hospitals likely to witness 20-22 percent revenue growth in FY2022: ICRA Medical Dialogues Bureau18 July 2021 9:00 AM IST"Overall, ICRA expects at least 200 bps improvement in profitability in FY2022, though the margins are expected to moderate from the level seen in Q4...
Aster DM expected to contain debt levels despite lower profitability: ICRA Farhat Nasim31 Aug 2020 9:30 AM ISTThe stable outlook reflects ICRA's expectations that the group's track record besides diversification across segments and geographies will aid in...
Hospitals may face more pricing restrictions: Rating agency ICRA Medical Dialogues Bureau7 July 2018 9:33 AM ISTMUMBAI: Regulatory overhang on the hospital sector is likely to persist, with further pricing restriction expected on products and services in the...
Govt needs to increase healthcare outlay in budget: Report savita thakur thakur16 Jan 2018 10:00 AM ISTMUMBAI: Public sector accounts for only 30 percent of the total healthcare expenditure in the country and investment in building and maintaining...
Healthcare sector may grow by 12-14 percent over next 5 years: ICRA savita thakur thakur3 March 2017 10:32 AM ISTMUMBAI: The health care sector is expected to witness an annual revenue growth of 12-14 per cent over the next five years due increasing medical...
Indian Pharma sector can touch Rs 4 lakh crore by 2020: Ananth Kumar savita thakur thakur14 Jan 2016 11:27 AM ISTNEW DELHI: Indian pharma sector can double in the next your years and touch Rs 4 lakh crore on the back of key policy initiatives of the government,...
